Medicare Enrolled
Dr. Victor Maquera, MD
Neurology · Orange Park, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maquera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maquera? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maquera
Dr. Victor Maquera is a neurology in Orange Park, FL, with 20 years in practice. Based on federal Medicare data, Dr. Maquera performed 3,249 Medicare services across 1,705 unique beneficiaries.
Between the years covered by Open Payments, Dr. Maquera received a total of $23,015 from 86 pharmaceutical and/or device companies across 1364 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maquera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 17% volume in FL$ $23,015 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,249
Medicare services
Top 17% in FL for neurology
1,705
Unique beneficiaries
$144
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~162 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Needle measurement of electrical activity in arm or leg muscles, complete study | 805 | $74 | $165 |
| Office visit, established patient (30-39 min) | 737 | $90 | $195 |
| Hospital follow-up visit, high complexity | 586 | $94 | $145 |
| Nerve conduction, 11-12 studies | 369 | $188 | $530 |
| New patient office visit, complex (60-74 min) | 129 | $158 | $400 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 71 | $322 | $800 |
| Measurement of brain wave activity (eeg), 12-26 hours with intermittent monitoring | 60 | $644 | $1,662 |
| Initial hospital admission, moderate complexity | 56 | $103 | $190 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with continuous monitoring | 54 | $1,016 | $2,500 |
| Ultrasound of both sides of head and neck blood flow | 51 | $137 | $275 |
| Office visit, established patient, complex (40-54 min) | 39 | $140 | $325 |
| Measurement of brain wave activity (eeg), continuous | 38 | $193 | $450 |
| Ultrasound of leg arteries or artery grafts | 37 | $182 | $350 |
| Nerve conduction, 13 or more studies | 33 | $220 | $610 |
| Sleep study in sleep lab (6 years or older) | 29 | $461 | $1,600 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 26 | $475 | $1,600 |
| Testing of autonomic nervous system function and heart rate response to deep breathing | 24 | $67 | $150 |
| Testing of autonomic (sympathetic) nervous system function | 24 | $94 | $280 |
| Measurement of brain wave activity (eeg), 61-84 hours with health care professional review and report | 20 | $189 | $410 |
| Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | 18 | $251 | $510 |
| Injection of trigger points, 1-2 muscles | 15 | $42 | $70 |
| Ultrasound of arm arteries or artery grafts | 14 | $133 | $250 |
| Sleep study including heart rate, breathing, airflow, and effort | 14 | $70 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$23,015
Total received (2018-2024)
Avg $3,288/year across 7 years
Top 14% in FL for neurology
86
Companies
1,364
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,708 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$307 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,484
2023$3,730
2022$3,567
2021$3,345
2020$2,501
2019$2,197
2018$2,191
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$2,062
ABBVIE INC.
$1,865
Novartis Pharmaceuticals Corporation
$1,463
EMD Serono, Inc.
$1,222
SK Life Science, Inc.
$1,108
UCB, Inc.
$852
Eisai Inc.
$832
GENZYME CORPORATION
$708
AbbVie Inc.
$650
Lilly USA, LLC
$574
Teva Pharmaceuticals USA, Inc.
$538
Amgen Inc.
$497
Avanir Pharmaceuticals, Inc.
$491
Genentech USA, Inc.
$487
Neurelis, Inc.
$474
EISAI INC.
$455
Allergan, Inc.
$446
Lundbeck LLC
$446
ANI Pharmaceuticals, Inc.
$420
PFIZER INC.
$407
JAZZ PHARMACEUTICALS INC.
$407
CSL Behring
$389
Corium, LLC
$376
Greenwich Biosciences, Inc.
$371
Alexion Pharmaceuticals, Inc.
$355
ARGENX US, INC.
$311
Otsuka America Pharmaceutical, Inc.
$273
Mallinckrodt Hospital Products Inc.
$267
Takeda Pharmaceuticals U.S.A., Inc.
$240
Resmed Corp
$240
Mallinckrodt LLC
$220
Grifols USA, LLC
$202
Jazz Pharmaceuticals Inc.
$194
Janssen Pharmaceuticals, Inc
$161
Sunovion Pharmaceuticals Inc.
$146
IMPEL PHARMACEUTICALS INC.
$136
Upsher-Smith Laboratories LLC
$136
Celgene Corporation
$136
LivaNova USA, Inc.
$134
Amneal Pharmaceuticals LLC
$123
Boston Scientific Corporation
$116
Inspire Medical Systems, Inc.
$114
Acorda Therapeutics, Inc
$111
UPSHER-SMITH LABORATORIES LLC
$96
E.R. Squibb & Sons, L.L.C.
$95
Scilex Pharmaceuticals Inc.
$86
Allergan Inc.
$81
Almatica Pharma LLC
$74
Biohaven Pharmaceuticals, Inc.
$74
Adamas Pharmaceuticals, Inc.
$73
CATALYST PHARMACEUTICALS, INC.
$67
Kyowa Kirin, Inc.
$66
SCILEX PHARMACEUTICALS INC.
$66
Merck Sharp & Dohme Corporation
$63
Catalyst Pharmaceuticals, Inc.
$62
IDORSIA PHARMACEUTICALS US INC
$59
TG Therapeutics, Inc.
$56
Axsome Therapeutics, Inc.
$54
Promius Pharma LLC
$53
HARMONY BIOSCIENCES LLC
$49
Neurocrine Biosciences, Inc.
$49
Biohaven Pharmaceutical Holding Company Ltd.
$41
Egalet US Inc
$40
Banner Life Sciences, LLC
$38
ASSERTIO THERAPEUTICS, Inc.
$38
Harmony Biosciences LLC
$36
Medtronic, Inc.
$35
Mallinckrodt Enterprises LLC
$33
ARBOR PHARMACEUTICALS, INC.
$30
Vertical Pharmaceuticals, LLC
$29
ACADIA Pharmaceuticals Inc
$28
Bausch Health US, LLC
$27
Avion Pharmaceuticals
$26
BANNER LIFE SCIENCES, LLC
$26
Merz Pharmaceuticals, LLC
$22
ASSERTIO THERAPEUTICS, INC.
$21
GE Healthcare
$20
Arbor Pharmaceuticals, Inc.
$18
Exeltis, USA Inc.
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
TG THERAPEUTICS, INC.
$17
GE HEALTHCARE
$16
Assertio Therapeutics, Inc.
$16
Supernus Pharmaceuticals, Inc.
$15
MDD US Operations, LLC
$14
Top 3 companies account for 23.4% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Actemra · Adlarity · Aimovig · AirSense · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX - SPASTICITY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CAPLYTA · COMIRNATY · COPAXONE · CREXONT · Dayvigo · Dhivy · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Epidiolex · Evrysdi · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INSPIRE · INTELLIS ADAPTIVESTIM · KESIMPTA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPRIX · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · XYREM · XYWAV · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $708 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
152
Per 100K population
68.0
County median income
$86,094
Nearest hospital
HCA FLORIDA ORANGE PARK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Maquera is a clinical cardiology specialist, with above-average Medicare volume (top 17% in FL), and high industry engagement (low-engagement, top 14%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Maquera experienced with needle measurement of electrical activity in arm or leg muscles, complete study?
Based on Medicare claims data, Dr. Maquera performed 805 needle measurement of electrical activity in arm or leg muscles, complete study services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maquera receive payments from pharmaceutical companies?
Yes. Dr. Maquera received a total of $23,015 from 86 companies across 1,364 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maquera's costs compare to other neurologys in Orange Park?
Dr. Maquera's average Medicare payment per service is $144. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maquera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Orange Park
Browse neurologys in Orange Park ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in FL
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in FL
Which FL neurologys receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc..
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology